Cameroon vs Fiji: Share of pregnant women with HIV that receive antiretroviral therapy
Cameroon
59.0%
in 2024
Fiji
57.0%
in 2024
Cameroon rank
62nd
Fiji rank
63rd
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Cameroon
- Fiji
How they compare
Cameroon currently reports 59.0% against 57.0% in Fiji, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Fiji ahead.
Cameroon ranks 62nd and Fiji ranks 63rd of 84 countries.
Across the 3 decades both report, Cameroon averaged higher in 2 and Fiji in 1.
Head to head by decade
| Decade | Cameroon | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.7% | 26.4% | 11.7% | Fiji |
| 2010s | 79.6% | 71.6% | 8.0% | Cameroon |
| 2020s | 74.0% | 31.0% | 43.0% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Cameroon or Fiji?
- Cameroon, at 59.0% against 57.0% in Fiji as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Cameroon and Fiji?
- 2.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Fiji?
- 25 years are reported by both, from 2000 to 2024.
- How do Cameroon and Fiji rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Cameroon ranks 62nd and Fiji ranks 63rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.